CLINICAL_TRIALS
trial_result
· 2011-03-22
Clinical Trial Update: 13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study [Phase 4]
Summary
A Phase 4 follow-on study of the 13-valent pneumococcal conjugate vaccine has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oxford | Conditions: Pneumococcal Disease | Phase 4 | Status: COMPLETED